Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Open Studies | "Yellow Fever"
Show Display Options
Rank Status Study
1 Recruiting Immune Responses to Yellow Fever Vaccine
Condition: Yellow Fever Vaccine
Intervention:
2 Recruiting Turnover of Antigen Specific Lymphocytes After Immunization With the Yellow Fever Vaccine
Condition: Yellow Fever
Interventions: Biological: Yellow fever vaccine;   Biological: Yellow fever vaccine and D20 water
3 Recruiting Human Immune Responses to The Yellow Fever Virus Vaccine
Condition: Yellow Fever
Intervention: Biological: Yellow fever vaccine
4 Recruiting A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow Fever
Interventions: Biological: MVA Smallpox Vaccine;   Biological: YF Vax 17D Strain;   Drug: ISA-720;   Biological: MVA-BN Yellow Fever Vaccine;   Other: Placebo
5 Recruiting Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Conditions: Yellow Fever Vaccine;   Immunity
Intervention: Biological: yellow fever vaccine
6 Recruiting Yellow Fever Vaccination Under Low Dose Methotrexate Therapy
Conditions: Rheumatic;   Dermatologic Disorders
Intervention: Biological: Yellow Fever Vaccination
7 Not yet recruiting Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
Condition: Malaria Vaccines
Interventions: Dietary Supplement: Vitamin A;   Biological: Candidate Plasmodium falciparum malaria vaccine;   Biological: MR-Vac;   Biological: Stamaril

Study has passed its completion date and status has not been verified in more than two years.